Press Releases

Date	Title	PDF Version
Oct 24, 2018	Alexion and Dicerna Announce Collaboration to Discover and Develop RNAi Therapies for Complement-Mediated Diseases
Oct 04, 2018	Alexion to Report Third Quarter 2018 Results on Wednesday, October 24, 2018
Sep 26, 2018	Alexion to Acquire Syntimmune
Sep 25, 2018	Alexion to Present at the Leerink Partners Roundtable Series: Rare Disease & Oncology
Sep 24, 2018	Alexion Announces Successful Phase 3 PREVENT Study of Soliris® (Eculizumab) in Patients with Neuromyelitis Optica Spectrum Disorder (NMOSD)
Sep 07, 2018	Alexion to Present at Morgan Stanley’s 16th Annual Global Healthcare Conference
Aug 29, 2018	Alexion to Present at Citi’s 13th Annual Biotech Conference
Aug 20, 2018	FDA Accepts Priority Review of ALXN1210 as a Treatment for Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH) in the US
Jul 26, 2018	Alexion Reports Second Quarter 2018 Results
Jun 28, 2018	Alexion to Report Second Quarter 2018 Results on Thursday, July 26, 2018

Search